CS logo
small CS logo
Kurume University Hospital

Kurume Shi, Fukuoka, Japan
University hospital in Kurume
67 Asahimachi, Kurume, Fukuoka 830-0011

About Kurume University Hospital


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Boehringer Ingelheim
11
Takeda
6
EMD Serono Research & Development Institute, Inc.
5
Kurume University
4
Pfizer
4
Biogen
3
Galapagos NV
3
Gilead Sciences
3
Ministry of Health, Labour and Welfare, Japan
3
Amgen
2
Boston Scientific Corporation
2
Total Rows: 30

Clinical Trials at Kurume University Hospital


During the past decade, Kurume University Hospital conducted 53 clinical trials. In the 10-year time frame, 53 clinical trials started and 21 clinical trials were completed, i.e. on average, 39.6% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 10 clinical trials were completed. i.e. 50% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years4412127733775510104411002211226622225511Started TrialsCompleted Trails201520162017201820192020202120222023051015
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study on the Prevalence of Heparin-Induced Thrombocytopenia in Cardiovascular Patients
2004-11-01
2006-03-01
Unknown status
1,500
Efficacy and Safety Study of Argatroban to Treat Heparin-Induced Thrombocytopenia
2005-06-01
2006-09-01
Completed
8
Anti-Inflammatory Effects of Pioglitazone
2007-05-01
2012-04-01
Completed
70
Study of Sorafenib In Combination With Low-dose 5-fluorouracil/Cisplatin (FP) Intraarterial Infusion Chemotherapy
2009-07-01
2010-10-01
Completed
37
Cardiac Sarcoidosis and FDG-PET
2004-03-01
2010-07-01
Completed
20
CS1008- in Combination With Sorafenib Compared to Sorafenib Alone in Subjects With Advanced Liver Cancer
2010-07-09
2013-09-09
Completed
172
Clinical Study Of Eplerenone In Japanese Patients With Chronic Heart Failure
2010-07-01
2015-09-01
Completed
221
Comparing Efficacy of Sorafenib Versus Sorafenib in Combination With Low-dose FP in Patients With Advanced HCC
2010-10-01
2013-09-01
Unknown status
190

Rows per page:

1–68 of 68

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Kurume University Hospital" #1 sponsor was "Boehringer Ingelheim" with 11 trials, followed by "Takeda" with 6 trials sponsored, "EMD Serono Research & Development Institute, Inc." with 5 trials sponsored, "Kurume University" with 4 trials sponsored and "Pfizer" with 4 trials sponsored. Other sponsors include 33 different institutions and companies that sponsored additional 30 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Kurume University Hospital" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 5 trials as a collaborator, "Gilead Sciences" with 3 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Duke Clinical Research Institute" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.
Created with Highcharts 11.1.0Top Leading SponsorsBoehringer Ingelheim: 11Boehringer Ingelheim: 11Takeda: 6Takeda: 6EMD Serono Research &Development Institute,Inc.: 5EMD Serono Research &Development Institute,Inc.: 5Kurume University: 4Kurume University: 4Pfizer: 4Pfizer: 4Biogen: 3Biogen: 3Galapagos NV: 3Galapagos NV: 3Gilead Sciences: 3Gilead Sciences: 3Ministry of Health,Labour and Welfare,Japan: 3Ministry of Health,Labour and Welfare,Japan: 3Amgen: 2Amgen: 2

Created with Highcharts 11.1.0Top CollaboratorsMerck KGaA,Darmstadt, Germany: 5Merck KGaA,Darmstadt, Germany: 5Gilead Sciences: 3Gilead Sciences: 3Arena is a whollyowned subsidiary ofPfizer: 1Arena is a whollyowned subsidiary ofPfizer: 1AstraZeneca: 1AstraZeneca: 1Duke Clinical ResearchInstitute: 1Duke Clinical ResearchInstitute: 1Eisai Inc.: 1Eisai Inc.: 1Galapagos NV: 1Galapagos NV: 1Japan Clinical OncologyGroup: 1Japan Clinical OncologyGroup: 1Korean GynecologicOncology Group: 1Korean GynecologicOncology Group: 1Mebix Inc: 1Mebix Inc: 1

Clinical Trials Conditions at Kurume University Hospital


According to Clinical.Site data, the most researched conditions in "Kurume University Hospital" are "Ulcerative Colitis" (5 trials), "Colitis, Ulcerative" (3 trials), "Crohn's Disease" (3 trials), "Lung Diseases, Interstitial" (3 trials) and "Muscular Atrophy, Spinal" (3 trials). Many other conditions were trialed in "Kurume University Hospital" in a lesser frequency.

Clinical Trials Intervention Types at Kurume University Hospital


Most popular intervention types in "Kurume University Hospital" are "Drug" (60 trials), "Device" (5 trials), "Other" (4 trials), "Biological" (1 trials) and "Combination Product" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (21 trials), "Nintedanib" (5 trials), "Filgotinib" (4 trials), "Nusinersen" (3 trials) and "Apremilast" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Kurume University Hospital


The vast majority of trials in "Kurume University Hospital" are 67 trials for "All" genders and 1 trials for "Female" genders.

Clinical Trials Status at Kurume University Hospital


Currently, there are NaN active trials in "Kurume University Hospital". undefined are not yet recruiting, 15 are recruiting, 13 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 31 completed trials in Kurume University Hospital, undefined suspended trials, and 4 terminated clinical trials to date.
Out of the total trials that were conducted in Kurume University Hospital, 2 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 39 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 4 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 39Phase 3: 39Phase 2: 16Phase 2: 16Phase 4: 5Phase 4: 5Not Applicable: 4Not Applicable: 4Phase 1: 2Phase 1: 2

Created with Highcharts 11.1.0Trials StatusCompleted: 31Completed: 31Recruiting: 15Recruiting: 15Active, not recruiting: 13Active, not recruiting: 13Terminated: 4Terminated: 4Unknown status: 3Unknown status: 3Enrolling by invitation: 2Enrolling by invitation: 2